Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.890 | 4.890 | 0.000 |
Shares | 95.110 | 95.110 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.676 | 15.872 |
Price to Book | 3.262 | 2.089 |
Price to Sales | 2.057 | 1.212 |
Price to Cash Flow | 12.687 | 9.464 |
Dividend Yield | 1.615 | 2.561 |
5 Years Earnings Growth | 10.468 | 13.640 |
Name | Net % | Category Average |
---|---|---|
Technology | 28.090 | 19.948 |
Healthcare | 22.680 | 12.387 |
Industrials | 18.590 | 25.153 |
Financial Services | 11.670 | 10.912 |
Consumer Cyclical | 6.220 | 14.011 |
Basic Materials | 6.070 | 6.503 |
Communication Services | 4.220 | 5.517 |
Consumer Defensive | 2.470 | 5.348 |
Number of long holdings: 61
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Boku | USU7744C1063 | 4.72 | 165.00 | 0.00% | |
Teqnion | SE0012308088 | 3.38 | 196.6000 | +1.24% | |
Diploma | GB0001826634 | 3.30 | 4,362.00 | +0.79% | |
JTC PLC | JE00BF4X3P53 | 2.96 | 1,084.00 | +3.24% | |
JDC Group | DE000A0B9N37 | 2.91 | 21.20 | -2.30% | |
Games Workshop | GB0003718474 | 2.60 | 11,700.0 | +0.95% | |
SDI Group | GB00B3FBWW43 | 2.52 | 52.50 | -0.94% | |
Dermapharm | DE000A2GS5D8 | 2.40 | 31.95 | -0.47% | |
Niox PLC | GB00BJVD3B28 | 2.36 | 63.80 | -3.33% | |
AAK | SE0011337708 | 2.35 | 340.0 | +0.12% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Inv SICAV Euro SCap I | 162.67M | 6.90 | -6.21 | 8.69 | ||
Danske Inv SICAV Euro I | 74.57M | 10.55 | 5.63 | 7.30 | ||
Danske Invest S Europe High Dividee | 46.59M | 11.34 | 8.61 | 6.43 | ||
Danske Invest S Europe High Dividea | 46.59M | 0.93 | 8.56 | 5.37 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review